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Patient engagement with treatments potentially poses problems for interpreting the
results and meaning of Randomised Control Trials (RCTs). If patients are assigned to
treatments that do, or do not, match their expectations, and this impacts their motivation
to engage with that treatment, it will affect the distribution of outcomes. In turn, this will
impact the obtained power and error rates of RCTs. Simple Monto Carlo simulations
demonstrate that these patient variables affect sample variance, and sample kurtosis.
These effects reduce the power of RCTs, and may lead to false negatives, even when the
randomisation process works, and equally distributes those with positive and negative
views about a treatment to a trial arm.
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INTRODUCTION
The Randomised Control Trial (RCT) is a flexible tool, capable of addressing many questions in
clinical settings, grounded on the notion that outcomes have not been differentially determined
by factors other than allocated treatment. Based on this assumption, RCTs allow causal evidence
that a treatment leads to an improvement, and this improvement cannot be attributed to any
characteristic other than the treatment. Consequently, RCTs remain the “gold standard” for
assessing treatment efficacy, and great weight is given to their findings in informing official
practise guidelines.
Nevertheless, debate about the use and value of RCTs in clinical practise has been vibrant and
ongoing acrossmany different healthcare fields. In particular, the notion that patient-characteristics
are not of “first line” importance in assessing outcomes jars with contemporary conjoint
decision-making practises in health settings. Recognising the patient as an active collaborator in
their treatment (co-production) has implications for how this research strategy should be viewed.
Moreover, it is apparent that patients” psychological characteristics, including how much they
engage with treatments, impact outcomes. The present perspective-article suggests that views
around the usefulness of RCTs, within many clinical settings, may benefit from consideration of
issues related to patient psychological characteristics.
Patient expectations may influence results, as randomisation to groups perceived as less
efficacious may increase attrition. However, effects of patient-characteristics on RCT outcomes
may go beyond attrition. Patient expectations and motivation may determine aspects of sample
statistics and trial results in ways that cannot be accommodated by RCTs. In particular, they may
reduce statistical power relating to patients who complete the trial. To illustrate debates about the
usefulness of RCTs, examples from the field of Physiotherapy will be used, as patient engagement
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with treatment is a key part of treatment effectiveness. A Monte
Carlo simulation will illustrate the possible impacts of patient
psychological characteristics on the distribution of data from
an RCT.
RCTs IN PHYSIOTHERAPY
There is little doubt that, within Physiotherapy, there is an
increasing trend toward usage of RCTs in assessing treatment
outcome-effectiveness (1, 2). Several reviews have noted an
increase in numbers of published RCT studies, over the last 40
years. Analysing data contained in the Physiotherapy Evidence
Database [PEDro; (3)], Kamper et al. (1) noted about 24,000 RCTs
had been published by 2014, compared to under 1,000 by 1980. A
similar pattern was observed by Kelly et al. (2), when examining
articles published in the journal, Physiotherapy.
Regardless of the absolute numbers, what is clear is that RCTs
are an increasing part of the evidence-base for Physiotherapy.
Figure 1 presents the percentage of RCT studies, published
across the past 40 years, falling into each successive 10-year
period, reported by Kamper et al. (1) and Kelly et al. (2). As
the two reviews employed different databases, with different
totals of studies, these figures are displayed as percentages.
Despite some differences, the trend toward increasing use of
RCTs is clear in both reports. Whether this trend reflects an
increasing acknowledgement that RCTs are the “gold standard,”
and should be adopted within Physiotherapy as a matter of
course (2), an increasing realisation that RCTs can be conducted
well in Physiotherapy (1), or an increasing recognition of the
reality that RCTs are important from policy-guidance panels, is
all debateable.
ASSESSING RCT QUALITY
Conducting an RCT is one thing; the RCT being of good quality
is another. If the objective is to impact clinical practise, then the
RCT needs to be of sufficient quality to be considered by policy-
guideline boards, like the Cochrane Database. The introduction
of the PEDro scale, to rate methodological rigour of RCTs
conducted in Physiotherapy, has been credited with helping to
improve their quality (3, 4). This scale includes items describing
various aspects of study design, which can be used to pinpoint
problems with a study, or summed to give an overall RCT-
quality score (5). According to a review conducted by Moseley
et al. (6), using the PEDro mean overall score, the quality of
RCTs in Physiotherapy has increased by about 0.6 points per
decade since 1960. Armijo-Olivo et al. (7) suggest that about 60%
of Physiotherapy RCTs evaluated were of an adequate quality,
according to the PEDro. Thus, focus on methodological rigour
of RCTs has served to improve their quality, which should be
beneficial for clinical practise.
Of key importance is the impact that RCT studies have
on practise and policy, and inclusion in Cochrane Reviews,
and/or NICE Guidelines, are key indices of potential impact.
The major problems with RCTs conducted in Physiotherapy,
which mirror those conducted in Clinical Psychology, are lacks
of both random sequence generation, and of concealed or
blind assignment, as suggested by the “Cochrane Risk of Bias”
tool. Lack of randomisation (or lack of detailed descriptions of
the process), lack of double-blinding of those delivering and
receiving interventions, and high attrition-rates which can be
differential across groups, are aspects that most often undermine
RCT quality. The three-item Jadad Scale has been used to assess
these aspects of RCTs (8). However, even if these issues could be
addressed, it would not mean that RCTs are always appropriate
devices to assess clinical outcomes. This debate has been aired to
a large extent in Physiotherapy, and it resonates with concerns
from Psychology applied to clinical settings.
CRITIQUES OF RCTs
The use of RCTs has not gone unchallenged in many healthcare
fields, and a number of articles have suggested that there may
be more appropriate approaches for Physiotherapy (9, 10), and
healthcare sciences in general (11, 12). While there is little
doubt of the commitment of most clinicians to evidence-based
medicine, this does not automatically mean a commitment
to RCTs (9). In fact, other approaches to evidence-collection
are widely used, and, sometimes, considered more appropriate
(13). Indeed, good-quality controlled studies, or prospective
observational studies, can provide better evidence than low-
quality RCTs, according to GRADE recommendations (14).
Djulbegovic and Guyatt (15) noted that overpowered RCTs,
with too strict inclusion criteria, and which include comparisons
with “no treatment” (very rarely a clinical option), will not give
evidence of any great practical value. Additionally, over-focus on
RCTs can relegate the “voice of clinical experience” down the
evidence-hierarchy (9); evidence-based medicine requires that
RCTs inform, but do not replace, clinical judgement (16).
In relation to Physiotherapy, Bithell (9) summarised many
objections to RCTs, relevant to any setting where patients play
active and co-productive roles in their treatments. The key
objections being: RCTs are time-consuming and expensive to
conduct, making them unlikely to impact clinical practise; it
is difficult to gain access to appropriate populations; and pre-
specified, invariable treatments are simply not appropriate, where
treatments have to adapt to individual patients. All of these points
are equally-applicable arguments within Clinical Psychology—
especially the final point. Clinically, what is important is the
manner in which an individual patient, not the average patient,
responds (13, 17).
Krauss (12) noted many potential areas of bias, that are
extremely difficult to overcome using the RCT-method, and
which apply equally in Physiotherapy and Clinical Psychology.
One in particular is highly relevant—that is, the patient tends
to change over time, in many ways. A fact that runs counter to
the “background-traits-remain-constant” assumption inherent in
RCTs. At the end of a trial, these influences can impact outcomes,
and bias results, just as much as at the beginning of a trial, but
these influences have not necessarily been randomised-out; the
longer the trial, the greater the likelihood of a biassing impact on
the outcome that these patient-changes will have.
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FIGURE 1 | Percentage of RCT studies, published across the past 40 years, falling into each successive 10-year period, reported by Kamper et al. (1) and
Kelly et al. (2).
The interaction between the intervention and the patient
is at the core of a critique of RCTs within Psychology (11).
As noted for Physiotherapy, treatments vary from session-to-
session, and often within sessions. This variation is not easy to
manualise, in anything other than a vague way. Moreover, the
particular therapy technique adopted is not the sole, nor perhaps
critical, variable producing treatment outcomes. Specifying the
treatment does not help understand what has gone on within
therapy sessions, as developing rapport with a patient, and
patient involvement, are also critical but nebulous (18).
In all of this debate, of central concern is the assumption
of causal-direction—the suggestion that the treatment produces
patient change. However, this assumes that patients are passive
recipients, and that their characteristics are, at best, an
inconvenience to the treatment (certainly to the RCT). Moreover,
if the independent variable (the treatment) interacts with the
dependent variable (the patient’s behaviour), that is, the therapy
changes as the patient’s behaviour changes, then the rationale
for the RCT is undermined. It is often assumed that random
assignment of patients to treatments reduces the impact of such
factors (19). However, as highlighted in the next sections, random
assignment might exacerbate this issue.
PATIENT CHARACTERISTICS
It is increasingly apparent in clinical practise that psychological
characteristics of patients, including how much they engage
with treatments, impact outcomes (20). A consideration reflected
in increased usage of patient motivational-supports (21).
Coupled with including patients as active contributors to
treatment-decisions, this consideration poses potential statistical
problems for interpreting RCT results.
If a patient is assigned to a treatment that does, or does
not, match their expectations, this could impact their motivation
to engage with that treatment, subsequently affecting their
treatment outcomes. This uncontrolled (and uncontrollable)
process may impact the obtained power and error rates of
RCTs, in ways that have not yet been thoroughly considered.
Such impacts on the ability to interpret statistical outcomes
could emerge through a number of routes, including effects
on: group differences, sample variances, and sample kurtoses—
each with statistical effects, and consequences, for RCTs, not yet
fully determined.
Simulations
To assess potential impacts of random assignment of individuals
to groups, which may or may not match their expectations,
Monto Carlo simulations, using 1,000 repetitions of each
scenario, determined effects on sample mean, standard deviation,
skewness, and kurtosis. For simplicity, it was assumed that an
intervention, without influence of patient motivation-to-engage,
would produce a normally distributed range of outcomes, with a
mean of 100, and a standard deviation of 15. It was also assumed
that patients could take one of three views of their treatment:
positive (adding to treatment effect); neutral (not altering
treatment effect); and negative (reducing treatment effect).
A number of simulations were conducted involving the effects
of: larger (N = 100) and smaller (N = 30) samples; a range of
impacts of motivation on outcomes (adding or subtracting 5, 10,
15, or 20 points to outcomes); and a range of proportions of
Frontiers in Medicine | www.frontiersin.org 3 June 2021 | Volume 8 | Article 648403
Truzoli et al. Patient Expectations and RCTs
FIGURE 2 | Means for the sample mean, standard deviation, skewness, and kurtosis, calculated under each condition. Bottom axes are the effect of motivation (5,
10, 15, 20), and the proportion of the sample taking a particular attitude to a treatment (0.1, 0.8, 0.1 = 10% negative, 80% neutral, 10% positive; 0.3, 0.4, 0.3 = 30%
negative, 40% neutral, 30% positive; 0.5,0, 0.5 = 50% negative, 0% neutral, 50% positive).
individuals adopting a particular stance toward a treatment (10%
positive/negative; 30% positive/negative; 50% positive/negative).
The means for the sample mean, standard deviation, skewness,
and kurtosis, were calculated under each condition (shown in
Figure 2).
Inspection of Figure 2 shows that two of the parameters
were affected by patients’ orientations toward the treatment:
the standard deviation, and the kurtosis; while the mean,
and the skewness, were not impacted. The effects grew
larger as the impact of the orientation increased, and were
most noticeable when the impact was to add/subtract 15,
or more, points to/from the outcome (i.e., one standard
deviation, or more). The effect was also more pronounced,
the greater the proportion of the sample who were taken
to adopt a particular stance toward the treatment. These
effects occurred for both small and large samples, even
with the randomisation being successful—that is, equal
numbers of patients taking positive and negative stances
toward the treatment. Thus, RCTs cannot overcome this
problem, and failing to account for patient preferences, by
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randomly assigning patients to treatments, may actually induce
this problem.
Impacts on Sample Variance
This effect is important, as the power of a statistical test is
negatively related to the variance. If some patients increase the
clinical outcome of the treatment (due to the match of their
assigned treatment with their expectations), and some patients
reduce their improvement (due to a mismatch), then the variance
in the sample is increased. As variance is inversely related to
power, this could reduce power for an RCT, making it harder
to reject the null hypothesis, and leading to more Type-2 errors.
Building on the current simulation, assuming an intervention-
group mean of 107.5, a control mean of 100, and standard
deviation (SD) of 15 (medium effect size), 94% power is achieved
with 100 participants per group, and 49% with 30 per group.
With an SD of 21, there is 71% power for 100 participants,
and 28% for 30 per group. When SD = 30, power drops
to 42% for 100 per group, and 16% for 30 per group. The
pronounced reduction may account for the relative difficulty
in establishing a statistically significant effect of a treatment
when an RCT is adopted, even when it is regularly seen in
controlled studies.
Impacts on Sample Distribution
The impact of patients taking positive or negative orientations
toward a treatment was to make the kurtosis negative; implying
a “flatter” (platykurtic) distribution of scores, with more data
in the “tails.” Although some extreme scorers are affected
by their expectations of treatment, it is necessarily the case
that more patients from the centre of the distribution will
move away from that centre to the extremes. Deviations
in kurtosis make parametric statistical tests less reliable,
and the power of a statistical test reduces as the excess
kurtosis increases (22), making Type-2 errors more likely.
As more data from two groups gather in their distribution
“tails,” there is more overlap, which reduces chances of
statistical significance. In fact, avoiding t-tests has been
recommended when there is such low kurtosis, due to low
power (23). An alternative might be to conduct non-parametric
tests, but these statistical procedures, on the whole, are
more conservative, and less powerful, than their parametric
alternatives, and this would not really solve the power/Type-2
error problem.
IMPLICATIONS
The effects of patient expectations and motivations on RCTs
opens new questions about the validity of these trials when patent
engagement is integral to treatment. The focus of this analysis was
face-to-face Physiotherapy and Psychotherapy. However, similar
considerations apply to pharmacological, and to computerised
physical or psychological, trials.
Patients randomised to treatments perceived as less efficacious
may prematurely terminate studies. Such attrition is a critical
consideration, and measuring compliance is essential. In drug
trials, pharmacokinetics (PK) and pharmacodynamics (PD)
assess compliance (24). PK characterises drug exposure through
absorption, distribution, metabolism, excretion; PD describes
biochemical and/ormolecular interactions. However, the impacts
on PK/PD of physiological responses engendered by assignment
to unwanted treatment is unknown.
Assessment of compliance and engagement with
Physiotherapy/Psychotherapy trials, beyond measuring
attendance, are less clear—especially when “homework”
is involved (21). To help assess compliance, treatment
procedures need careful description in protocols. Althoughmany
interventions are individually structured (9, 10), monitoring
compliance and fidelity of individualised interventions aids
trial-outcome reliability (25). Moreover, increasing motivation,
before and during interventions, may bolster treatment and trial
power; perhaps by adopting motivational and values support
training (21).
However, the current simulations imply that patient
expectations impact RCTs beyond compliance, affecting
sample statistics, reducing statistical power, and increasing
Type-2 errors (falsely denying treatment efficacy). This is
a harder issue to resolve, certainly affecting non-blinded
or single-blinded trials, where patients are informed about
their treatments. Double-blinded trials are considered
methodologically superior, but also will be subject to these
effects—patients become aware of the nature of their
physical/psychological therapies, and form their opinions
of these treatments, even when not explicitly informed
about the natures of their interventions (10). This may also
be true for pharmacological treatments where drugs have
discriminable physical effects. Moreover, it is not clear how
traditional physical and psychological treatments could (or
should) be blinded from the professionals delivering them
(11, 13).
Computerised therapies (e.g., digitised psychoeducational
pelvic-floor programmes, or Cognitive Behaviour Therapy
interventions) may not have to blind the delivery-agent,
but the investigated phenomenon will still be important, as
patient-engagement with the app is causal to clinical efficacy
(26). Given this, even double-blinded studies of digital-
delivery systems will be impacted by patent expectations and
motivations. Perhaps the optimal procedure is to measure
patient expectations/motivations to control for their effects,
although this acknowledges that RCTs per se do not control for
all problems.
CONCLUSION
The simulation suggests that, whenever patients are actively
engaged in their treatments, their expectations and motivations
play a role in compliance, and determine the power of the trials.
These considerations may be addressed in a variety of ways in
different fields (e.g., physical vs. pharmacological therapies), and
there are aspects of good practise that may mitigate some of
these deleterious effects on RCT outcomes. However, ultimately,
this may be regarded as a “brute” objection to RCTs that
cannot be controlled away, and the best that may be achievable
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is to measure the influence, and recognise the advantages of
alternative assessment-methodologies in some situations.
These considerations add to concerns over the assumption
that RCTs are the “gold standard” for determining the outcome-
effectiveness of any clinical treatment. If patient expectations
and preferences are important determinants of treatment-
outcomes, then the impact of these patient-variables on the
statistical interpretability of RCTs is a serious concern in
clinical settings. Given the increasing involvement of patients
in joint decision-making about their treatments, these concerns
would seem to warrant further attention being paid to
how to measure and approach such effects, due to their
potential adverse influences on the power and error rates
of RCTs.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
The authors acknowledge support from the University of Milan
through the APC initiative.
REFERENCES
1. Kamper SJ, Moseley AM, Herbert RD, Maher CG, Elkins MR, Sherrington C.
15 years of tracking physiotherapy evidence on PEDro, where are we now? Br
J Sports Med. (2015) 49:907–9. doi: 10.1016/j.physio.2015.03.3565
2. Kelly G, Reilly A, Moloney H, Moran J, Cunningham C, Broderick
J. 50 years of randomised controlled trials published in the journal
Physiotherapy: a review 1967 to 2017. Physiotherapy. (2018) 104:359–
66. doi: 10.1016/j.physio.2018.08.005
3. Blobaum PM. Physiotherapy evidence database (PEDro), (Electronic
Resource Review). J Med Libr Assoc. (2006) 94: 477–8.
4. Kamper SJ, Moseley AM, Herbert RD, Maher CG, Elkins MR, Sherrington C.
15 years of tracking physiotherapy evidence on PEDro, where are we now? Br
J Sports Med. (2015) 49:907–9. doi: 10.1136/bjsports-2014-094468
5. Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro scale
for rating quality of randomized controlled trials. Phys Ther. (2003) 83:713–
21. doi: 10.1093/ptj/83.8.713
6. Moseley AM, Herbert RD, Maher CG, Sherrington C, Elkins MR.
Reported quality of randomized controlled trials of physiotherapy
interventions has improved over time. J Clin Epidemiol. (2011)
64:594–601. doi: 10.1016/j.jclinepi.2010.08.009
7. Armijo-Olivo S, da Costa BR, Cummings GG, Ha C, Fuentes
J, Saltaji H, et al. PEDro or Cochrane to assess the quality of
clinical trials? A meta-epidemiological study. PLoS ONE. (2015)
10:e0132634. doi: 10.1371/journal.pone.0132634
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM,
Gavaghan DJ, et al. Assessing the quality of reports of randomized
clinical trials: is blinding necessary? Controll Clin Trials. (1996)
17:1–12. doi: 10.1016/0197-2456(95)00134-4
9. Bithell C. Evidence-based physiotherapy: some thoughts on ‘best evidence’.
Physiotherapy. (2000) 86:58–9. doi: 10.1016/S0031-9406(05)61206-0
10. DijkersMP,Murphy SL, Krellman J. Evidence-based practice for rehabilitation
professionals: concepts and controversies. Arch Phys Med Rehabil. (2012)
93:S164–76. doi: 10.1016/j.apmr.2011.12.014
11. Carey TA, Stiles WB. Some problems with randomized controlled trials
and some viable alternatives. Clin Psychol Psychother. (2016) 23:87–
95. doi: 10.1002/cpp.1942
12. Krauss A. Why all randomised controlled trials produce biased results. Ann
Med. (2018) 50:312–22. doi: 10.1080/07853890.2018.1453233
13. van Trijffel E, Oostendorp R, Elvers JH. Routinely collected data as real-
world evidence for physiotherapy practice. Physiother Theory Pract. (2019)
35:805–9. doi: 10.1080/09593985.2019.1615678
14. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J,
et al. GRADE guidelines: 1. Introduction—GRADE evidence
profiles and summary of findings tables. J Clin Epidemiol. (2011)
64:383–94. doi: 10.1016/j.jclinepi.2010.04.026
15. Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter
century on. Lancet. (2017) 390:415–23. doi: 10.1016/S0140-6736(16)31592-6
16. Sackett DL, Rosenberg WM, Gray JM, Haynes RB, Richardson WS.
Evidence based medicine: what it is and what it isn’t. BMJ. (1996) 312:71–
2. doi: 10.1136/bmj.312.7023.71
17. Tonelli MR. In defense of expert opinion. Acad Med. (1999) 74:1187–
92. doi: 10.1097/00001888-199911000-00010
18. Gomes-Schwartz B. Effective ingredients in psychotherapy: Prediction
of outcome from process variables. J Consult Clin Psychol. (1978)
46:1023. doi: 10.1037/0022-006X.46.5.1023
19. Krause MS, Howard KI. What random assignment does and
does not do. J Clin Psychol. (2003) 59:751–66. doi: 10.1002/jclp.
10170
20. Reed P, Osborne LA, Whittall CM, Emery S. Impact of patient
motivation on compliance and outcomes for incontinence. Physiotherapy.
(2020). doi: 10.1016/j.physio.2020.10.003
21. Osborne LA, Whittall CM, Edwards DJ, Emanuel R, Emery S, Reed
P. Randomised control trial of a values-based motivational interview
support to promote attendance at pelvic floor muscle training
physiotherapy treatment. J Pelvic Obstetr Gynaecol Physiother. (2016) 119:
38–46.
22. Foldnes N, Olsson UH, Foss T. The effect of kurtosis on the power of two
test statistics in covariance structure analysis. Br J Math Stat Psychol. (2012)
65:1–18. doi: 10.1111/j.2044-8317.2010.02010.x
23. Garren ST, Osborne KM. Robustness of t-test based on
skewness and kurtosis. J Adv Math Comp Sci. (2021)
36:102−110. doi: 10.9734/jamcs/2021/v36i230342
24. Hartigan SM, Dmochowski RR. Gender specific pharmacokinetic
and pharmacodynamic considerations for antimuscarinic drugs for
overactive bladder treatment. Exp Opin Drug Metab Toxicol. (2020)
16:103–10. doi: 10.1080/17425255.2020.1714591
25. Sanetti LM, Cook BG, Cook L. Treatment fidelity: what it is and why
it matters. Learn Disabil Res Pract. (2021) 36:5–11. doi: 10.1111/ldr
p.12238
26. Bakker D, Rickard N. Engagement with a cognitive behavioural
therapy mobile phone app predicts changes in mental health and
wellbeing: MoodMission. Aust Psychol. (2019) 54:245–60. doi: 10.1111/
ap.12383
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Truzoli, Reed and Osborne. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Medicine | www.frontiersin.org 6 June 2021 | Volume 8 | Article 648403
